Please use this identifier to cite or link to this item: http://repo.jfn.ac.lk/med/handle/701/1562
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSanchayan, K.-
dc.contributor.authorFernandopulle, R.-
dc.contributor.authorAmarasinghe, A.-
dc.contributor.authorThiyahiny, S.N.-
dc.contributor.authorSri Ranganathan, S.-
dc.date.accessioned2017-04-03T05:20:42Z-
dc.date.accessioned2022-09-17T06:50:04Z-
dc.date.available2017-04-03T05:20:42Z-
dc.date.available2022-09-17T06:50:04Z-
dc.date.issued2017-
dc.identifier.citationCeylon Medical Journal 2017; 62: 12-19en_US
dc.identifier.urihttp://repo.jfn.ac.lk/med/handle/701/1562-
dc.language.isoenen_US
dc.subjectAdverse events following immunisationen_US
dc.subjectMMR vaccineen_US
dc.subjectCausalityen_US
dc.subjectCohort event monitoringen_US
dc.titleActive safety monitoring of measles-mumps-rubella vaccine in the National Immunisation Programme of Sri Lankaen_US
dc.typeJournal full texten_US
Appears in Collections:Pharmacology

Files in This Item:
File Description SizeFormat 
dr.k.muhunthiny.pdf212.8 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.